COVID-19 Disease and Vitamin D: A Mini-Review

Author:

Boulkrane Mohamed Said,Ilina Victoria,Melchakov Roman,Fedotova Julia,Drago Filippo,Gozzo Lucia,Das Undurti Narasimha,Abd El-Aty A. M.,Baranenko Denis

Abstract

Novel coronavirus disease (COVID-19) pandemic caused by SARS-CoV-2, for which there is no effective treatment except employing prevention strategies, has already instituted significant number of deaths. In this review, we provide a scientific view on the potential role of vitamin D in SARS-CoV-2 virus/COVID-19 disease. Vitamin D is well-known to play a significant role in maintaining the immune health of an individual. Moreover, it induces antimicrobial peptide expression that can decrease viral replication and regulate the levels of pro-inflammatory/anti-inflammatory cytokines. Therefore, supplementation of vitamin D has the potential to reduce the incidence, severity and the risk of death from pneumonia resulting from the cytokine storm of many viral infections including COVID-19. We suggest that supplementation of subjects at high risk of COVID-19 with vitamin D (1.000 to 3.000 IU) to maintain its optimum serum concentrations may be of significant benefit for both in the prevention and treatment of the COVID-19.

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference121 articles.

1. Vitamin d-directed rheostatic regulation of monocyte antibacterial responses;Adams;J. Immunol.,2009

2. Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonists;Adorini;Hum. Immunol.,2009

3. Cathelicidin impact on inflammatory cells;Agier;Cent. Eur. J. Immunol.,2015

4. Letter-preprint vitamin D supplementation could possibly improve clinical outcomes of patients infected with coronavirus-2019 (Covid-2019) AlipioM. M. 2020

5. Vitamin D deficiency 2.0: an update on the current status worldwide;Amrein;Eur. J. Clin. Nutr.,2020

Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3